FOLH1 and neoplasm: Consequently, endocytosis or the fusion of PSMA-positive membranes in normal endothelial cells may be an attractive target for the development of new anti-angiogenic agents that inhibit the transformation of normal endothelial cells into PSMA-positive tumor endothelial cells.